In
chronic kidney disease,
vitamin K-dependent
proteins, including the calcification inhibitor
matrix Gla protein, are largely uncarboxylated indicating that functional
vitamin K deficiency may contribute to uremic
vascular calcification. Since the effects of
uremia on the
vitamin K cycle are unknown, we investigated the influence of
uremia and
vitamin K supplementation on the activity of the
vitamin K cycle and extraosseous calcification.
Uremia was induced in rats by an
adenine-supplemented diet and
vitamin K1 or K2 was administered over 4 and 7 weeks. After 4 weeks of
adenine diet, the activity of the
vitamin K cycle
enzyme γ-carboxylase but not the activities of
DT-diaphorase or
vitamin K epoxide reductase were reduced. Serum levels of undercarboxylated
matrix Gla protein increased, indicating functional
vitamin K deficiency. There was no light microscopy-detectable calcification at this stage but chemically determined aortic and renal
calcium content was increased.
Vitamin K treatment reduced aortic and renal
calcium content after 4 weeks. Seven weeks of
uremia induced overt calcification in the aorta, heart, and kidneys; however, addition of
vitamin K restored intrarenal γ-carboxylase activity and overstimulated it in the liver along with reducing heart and kidney calcification. Thus, uremic
vitamin K deficiency may partially result from a reduction of the γ-carboxylase activity which possibly contributes to calcification. Pharmacological
vitamin K supplementation restored the
vitamin K cycle and slowed development of soft tissue calcification in experimental
uremia.